MitchellJHMaronBJEpsteinSE. 16th Bethesda Conference: cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. J Am Coll Cardiol. 1985;6(6):1186–1232.
2.
MaronBJMitchellJH. 26th Bethesda Conference: cardiovascular abnormalities: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. J Am Coll Cardiol. 1994;24(4):845–899.
3.
MaronBJZipesDP. 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2005;45(8):2–64.
4.
MaronBJZipesDPKovacsRJ; on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a Scientific Statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e2562–e2661.
5.
Van HareGFAckermanMJEvangelistaJK; on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 4: congential heart disease: a Scientific Statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e281–e291.
6.
MaronBJDoererJJHaasTSTierneyDMMuellerFO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119(8):1085–1092.
DavisJACecchinFJonesTKPortmanMA. Major coronary artery anomalies in a pediatric population: incidence and clinical importance. J Am Coll Cardiol. 2001;37(2):593–597.
9.
AngeliniP. Novel imaging of coronary artery anomalies to assess their prevalence, the causes of clinical symptoms, and the risk of sudden cardiac death. Circ Cardiovasc Imaging. 2014;7(4):747–754.
10.
AngeliniPVelascoJAFlammS. Coronary anomalies: incidence, pathophysiology, and clinical relevance. Circulation. 2002;105(20):2449–2454.
11.
CheitlinMDDeCastroCMMcAllisterHA. Sudden death as a complication of anomalous left coronary origin from the anterior sinus of Valsalva. Circulation. 1974;50(4):780–787.
12.
BassoCMaronBJCorradoDThieneG. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol. 2000;35(6):1493–1501.
13.
HillSFSheppardMN. A silent cause of sudden cardiac death especially in sport: congenital coronary artery anomalies. Br J Sports Med. 2014;48(15):1151–1156.
14.
TaylorAJByersJPCheitlinMDVirmaniR. Anomalous right or left coronary artery from the contralateral coronary sinus: high risk abnormalities in the initial coronary artery course and heterogeneous clinical outcomes. Am Heart J. 1997;133(4):428–435.
15.
RobertsWCSiegelRJZipesDP. Origin of the right coronary artery from the left sinus of Valsalva and its functional consequences: analysis of 10 necropsy patients. Am J Cardiol. 1982;49(4):863–868.
16.
FrescuraCBassoCThieneG. Anomalous origin of coronary arteries and risk of sudden death: a study based on an autopsy population of congenital heart disease. Hum Pathol. 1998;29(7):689–695.
17.
MaronBJRobertsWCMcAllisterHARosingDREpsteinSE. Sudden death in young athletes. Circulation. 1980;62(2):218–229.
18.
McNamaraDGBrickerJTGaliotoFMGrahamTPJamesFWRosenthalA. The 16th Bethesda conference on cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force 1: congenital heart disease. J Am Coll Cardiol. 1985;6(6):1200–1208.
19.
GrahamTPJrBrickerJTJamesFWStrongWB. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task force 1: congenital heart disease. J Am Coll Cardiol. 1994;24(4):867–873.
20.
GrahamTPJrDriscollDJGersonyWMNewburgerJWRocchiniATowbinJA. Task Force 2: congenital heart disease. J Am Coll Cardiol. 2005;45(8):1326–1333.
21.
TaylorAJRoganKMVirmaniR. Sudden cardiac death associated with isolated congenital coronary artery anomalies. J Am Coll Cardiol. 1992;20(3):640–647.
22.
HarmonKGDreznerJAWilsonMGSharmaS. Incidence of sudden cardiac death in athletes: a state-of-the-art review. Heart. 2014;100(16):1227–1234.
23.
BrothersJCarterCMcBrideMSprayTParidonS. Anomalous left coronary artery origin from the opposite sinus of Valsalva: evidence of intermittent ischemia. J Thorac Cardiovasc Surg. 2010;140(2):e27–e29.
24.
MaronBJHaasTSAhluwaliaARutten-RamosSC. Incidence of cardiovascular sudden deaths in Minnesota high school athletes. Heart Rhythm. 2013;10(3):374–377.
25.
MeyerLStubbsBFahrenbruchC. Incidence, etiology, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults ages 0-35: A 30-year review. Circulation. 2012;126(11):1363–1372.
26.
PilmerCMKirshJAHildebrandtDKrahnADGowRM. Sudden cardiac death in children and adolescents between 1 and 19 years of age. Heart Rhythm. 2014;11(2):239–245.
27.
PoynterJAWilliamsWGMcIntyreSBrothersJAJacobsML; Congenital Heart Surgeons’ Society AAOCA Working Group. Anomalous aortic origin of a coronary artery: a report from the Congenital Heart Surgeons’ Society Registry. World J Pediatr Congenit Heart Surg. 2014;5(1):22–30.
